122 related articles for article (PubMed ID: 35434697)
1. Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
Dong X; Tsang CCS; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
Explor Res Clin Soc Pharm; 2021 Sep; 3():. PubMed ID: 35434697
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
[TBL] [Abstract][Full Text] [Related]
3. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
[TBL] [Abstract][Full Text] [Related]
4. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
[TBL] [Abstract][Full Text] [Related]
7. Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.
Dong X; Tsang CCS; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Browning JA; Garuccio J; Zeng R; Wang J
Explor Res Clin Soc Pharm; 2024 Mar; 13():100420. PubMed ID: 38420610
[TBL] [Abstract][Full Text] [Related]
8. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
[TBL] [Abstract][Full Text] [Related]
10. Application of the nonlinear Blinder-Oaxaca decomposition to study racial/ethnic disparities in antiobesity medication use in the United States.
Mehta HB; Rajan SS; Aparasu RR; Johnson ML
Res Social Adm Pharm; 2013; 9(1):13-26. PubMed ID: 22554395
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic disparities in the enrolment of medicare medication therapy management programs.
Garuccio J; Tsang CCS; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Browning JA; Zeng R; Wang J
J Pharm Health Serv Res; 2023 Jun; 14(2):188-197. PubMed ID: 37337596
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
[No Abstract] [Full Text] [Related]
13. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.
Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC
Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.
Dong X; Tsang CCS; Zhao S; Browning JA; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Hines LE; Wang J
Curr Med Res Opin; 2021 Sep; 37(9):1581-1588. PubMed ID: 34039232
[TBL] [Abstract][Full Text] [Related]
15. Disparities associated with Medicare Part D Star Ratings measures among patients with Alzheimer's disease and related dementias.
Tsang CCS; Zhang X; Barenie RE; Cernasev A; Miller NA; Wan JY; Tsao JW; Wang J
Medicine (Baltimore); 2023 May; 102(18):e33641. PubMed ID: 37144996
[TBL] [Abstract][Full Text] [Related]
16. Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.
Wang J; Qiao Y; Shih YC; Jamison JJ; Spivey CA; Li L; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
Am Health Drug Benefits; 2014 Sep; 7(6):346-58. PubMed ID: 25558303
[TBL] [Abstract][Full Text] [Related]
17. Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.
Dong X; Tsang CCS; Browning JA; Sim Y; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J
Curr Med Res Opin; 2023 Jul; 39(7):963-971. PubMed ID: 37219396
[TBL] [Abstract][Full Text] [Related]
18. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.
Wang J; Surbhi S; Zhang Z; Spivey CA; Chisholm-Burns M
Res Social Adm Pharm; 2014; 10(6):904-917. PubMed ID: 25458405
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.
Browning J; Tsang CCS; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Wang J
J Am Pharm Assoc (2003); 2022; 62(1):142-149. PubMed ID: 34509379
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of medication therapy management among Medicare population and across racial/ethnic groups.
Tsang CCS; Wang J; Shih YT
Medicine (Baltimore); 2024 May; 103(18):e37935. PubMed ID: 38701304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
